Related Experiment Videos
Future options for therapies to limit damage and enhance recovery
1University of Cambridge Neurology Unit, Addenbrooke's Hospital, United Kingdom.
Seminars in Neurology
|November 17, 1998
Summary
Future multiple sclerosis treatments will leverage therapeutic immunology to inhibit central nervous system inflammation. Understanding disease progression is key to timing interventions and promoting axon repair alongside limiting damage.
Area of Science:
- Neuroimmunology
- Neurobiology
Background:
- Multiple sclerosis (MS) pathogenesis understanding has yielded modest disease-modifying treatments.
- Therapeutic immunology insights are crucial for future MS intervention strategies.
Purpose of the Study:
- To inhibit the inflammatory cascade in the central nervous system (CNS) targeting myelinated axons in MS.
- To correlate disease progression events with clinical course for optimized treatment timing.
Main Methods:
- Applying insights from therapeutic immunology to target CNS inflammation.
- Correlating the sequence of inflammation, demyelination, and axon degeneration with clinical MS progression.
Main Results:
- Current treatments modestly modify the course of multiple sclerosis.
- Future treatment strategies will focus on inhibiting inflammatory events and targeting myelinated axons.
Conclusions:
- Optimizing MS treatment requires understanding the sequence of pathological events and their correlation with clinical outcomes.
- Future research should explore strategies for both limiting MS disease processes and promoting axonal repair/remyelination.